Nozac (Nebivolol Hydrochloride)

Nebivolol selectively blocks β1‑adrenergic receptors in the heart, reducing sympathetic stimulation, heart rate, and contractility. It also stimulates endothelial nitric‑oxide release, causing vasodilation. The combined actions lower systemic vascular resistance and arterial pressure.

The appropriate dose of Nozac is determined by the prescribing healthcare professional based on the individual’s blood‑pressure profile, age, renal and hepatic function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for nebivolol in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Nozac, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nebivolol differs from many antihypertensives by combining selective β1‑blockade with nitric‑oxide‑mediated vasodilation, offering both heart‑rate reduction and arterial relaxation. Compared with non‑selective beta‑blockers, it has fewer bronchospastic effects, and unlike pure vasodilators, it also lowers heart rate, providing a balanced blood‑pressure‑lowering profile.

Nozac should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Nozac is taken orally, usually with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed by a healthcare professional.

Serious risks include severe bradycardia, marked hypotension, and rare allergic reactions such as angio‑edema. Patients should seek immediate medical attention if they experience fainting, very slow heart rate, severe dizziness, or signs of an allergic response.

Nozac is contraindicated in patients with known hypersensitivity to nebivolol or any excipients, those with severe bradycardia, second‑ or third‑degree atrioventricular block without a pacemaker, and individuals with uncompensated heart failure. Caution is also advised in patients with severe hepatic impairment.